In contrast to T2D, CF islets do not express the IL-1β antagonist, IL-1Rα, suggesting that the bio-activity of IL-1β is even higher in CFRD than in T2D (43). The gene discussed is IL1B; the disease is cystic fibrosis-related diabetes.